MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Yes! Independence Day is observed on Thursday, July 4, this year, and is considered a federal holiday. In total, 2025 has 12 ...

After much of the weight is lost, patients could remain on a maintenance dose that requires only a few administrations a year. In a Phase 2 trial , patients treated with monthly MariTide without ...

As of May 22, manufacturers are no longer allowed to distribute the compounded versions of semaglutide, which Novo Nordisk sells under the brand Wegovy for weight loss and Ozempic for diabetes.

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone density at the highest dose.

Chart Rating Changes Sections. Markets. Funds ... Weight-loss-drug price war is on, ... The 7.5-milligram dose of Zepbound will cost $599 a month and the 10-milligram dose will cost $699 a ...

we’re shining a spotlight on cardiovascular care. today, we’re exploring how weight loss medications are playing a role in preventing heart disease. joining me this morning is doctor vijay. casey.